Terveystalo (TTALO) Jefferies London Healthcare Conference 2024 summary
Event summary combining transcript, slides, and related documents.
Jefferies London Healthcare Conference 2024 summary
3 Feb, 2026Business overview and market position
Leading Nordic healthcare platform with €1.3 billion revenue, focused on private outpatient services.
Operates over 300 units in Finland and 150 in Sweden, with growing digital presence.
61% of revenue from corporate clients, 30% from consumers, and 9% from public sector.
Integrated care model offers fast, 24/7 access to both digital and physical services.
15,000 professionals serve 1.2 million customers, mainly in Finland.
Financial performance and turnaround
EBITDA margin improved from below 8% to 12.3% over 24 months, surpassing targets.
Achieved profitability and growth despite negative consumer and corporate confidence in Finland.
Turnaround driven by commercial actions, productivity boosts, and cost cutting.
No market segment provided external growth boost; all improvements were internal.
Future focus shifts from turnaround to organic growth and technology investment.
Strategic direction and growth drivers
Ongoing investments in digital integration and AI-driven applications to enhance efficiency.
Customer satisfaction and medical quality KPIs at all-time highs.
Positioned to benefit from widening public funding and productivity gaps in healthcare.
Demographic trends and rising service prices support long-term market growth.
Scalable, digital-driven business model with strong cash flow for reinvestment and shareholder rewards.
Latest events from Terveystalo
- Profitability hit record highs despite lower revenue, with 2026 outlook cautious but optimistic.TTALO
Q4 202513 Feb 2026 - Profitable growth and market leadership driven by digitalization and integrated care.TTALO
CMD 202412 Jan 2026 - Strong revenue and profit growth in 2024, with improved margins and robust 2025 outlook.TTALO
Q4 202427 Dec 2025 - Profitability and EPS surged in Q1 2025, driven by Healthcare Services and margin gains.TTALO
Q1 202523 Dec 2025 - Record Q2 EBIT and margin, EPS up 55%, with strong 2025 outlook despite lower revenue.TTALO
Q2 202516 Nov 2025 - Margins and EPS rose despite a 5.2% revenue drop, with 2025 guidance reaffirmed.TTALO
Q3 202523 Oct 2025 - Q3 2024 earnings and margins surged, with profitability targets reached early.TTALO
Q3 202413 Jun 2025 - Record Q2 results and raised 2024 guidance driven by strong margin and profit growth.TTALO
Q2 202413 Jun 2025